Literature DB >> 25633124

Blood transfusion in hip and knee arthroplasties: the end of the pre-operative group and save?

B A Marson1, J Shah, M Deglurkar.   

Abstract

Total hip and knee replacements (THR and TKR) are a common procedure. Transfusion rates have fallen in the literature over the past decade, and this study aimed to quantify the transfusion rates and identify the clinical transfusion threshold in our centre, which uses a multimodal enhanced recovery after surgery (ERAS) programme. A retrospective review of case notes from a 12-month period identified 997 patients undergoing primary THR or TKR. 4.1 % of the patients undergoing THR and 1.4 % of patients undergoing TKR required blood transfusion. 61 % of patients receiving blood transfusions had pre-transfusion haemoglobin levels >80 gl(-1). One patient required blood on the day of surgery. With the ERAS programme, transfusion rates are low and very rarely blood is required on the day of surgery. We would suggest that routine pre-operative group and save or cross-match testing may no longer be essential, as long as there is a stock of O- blood for the rare emergency issues.

Entities:  

Mesh:

Year:  2015        PMID: 25633124     DOI: 10.1007/s00590-015-1597-2

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  21 in total

1.  The routine use of tranexamic acid in hip and knee replacements.

Authors:  Jaykar R Panchmatia; Soudeh Chegini; Charlotte Lobban; Guarangkumar Shah; Clare Stapleton; Jayne M B Smallman; Rakesh Kucheria
Journal:  Bull NYU Hosp Jt Dis       Date:  2012

2.  Group and save is safe and cost effective in elective total hip arthroplasty: completion of an audit cycle.

Authors:  C S Kwok; S H White; T J Brammar
Journal:  Transfus Med       Date:  2012-10-15       Impact factor: 2.019

3.  Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement.

Authors:  J M Murkin; G M Haig; K J Beer; N Cicutti; J McCutchen; M E Comunale; R Hall; B B Ruzicka
Journal:  J Bone Joint Surg Am       Date:  2000-05       Impact factor: 5.284

4.  Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe.

Authors:  Nadia Rosencher; Hans E M Kerkkamp; G Macheras; L M Munuera; G Menichella; David M Barton; Saskia Cremers; Ivo L Abraham
Journal:  Transfusion       Date:  2003-04       Impact factor: 3.157

5.  Transfusion-related mortality after primary hip arthroplasty--an analysis of mechanisms and confounders.

Authors:  Ø Jans; H Kehlet; P I Johansson
Journal:  Vox Sang       Date:  2012-04-20       Impact factor: 2.144

6.  The effect of a preoperative erythropoietin protocol as part of a multifaceted blood management program in daily clinical practice (CME).

Authors:  Hieronymus J Doodeman; Ingrid M M van Haelst; Toine C G Egberts; Martin Bennis; Han S Traast; Wouter W van Solinge; Cor J Kalkman; Wilton A van Klei
Journal:  Transfusion       Date:  2012-12-12       Impact factor: 3.157

7.  The use of enhanced recovery after surgery (ERAS) principles in Scottish orthopaedic units--an implementation and follow-up at 1 year, 2010-2011: a report from the Musculoskeletal Audit, Scotland.

Authors:  Nicholas B Scott; David McDonald; Jane Campbell; Richard D Smith; A Kate Carey; Ian G Johnston; Kate R James; Steffen J Breusch
Journal:  Arch Orthop Trauma Surg       Date:  2012-10-16       Impact factor: 3.067

8.  The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery.

Authors:  Nicolai B Foss; Morten Tange Kristensen; Pia Søe Jensen; Henrik Palm; Michael Krasheninnikoff; Henrik Kehlet
Journal:  Transfusion       Date:  2009-02       Impact factor: 3.157

9.  Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied.

Authors:  Juan C Alvarez; Francisco X Santiveri; Isabel Ramos; Enrique Vela; Lluis Puig; Fernando Escolano
Journal:  Transfusion       Date:  2007-12-07       Impact factor: 3.157

10.  Clinical experience with tranexamic acid during primary total hip arthroplasty.

Authors:  Gerard M March; Salah Elfatori; Paul E Beaulé
Journal:  Hip Int       Date:  2013 Jan-Feb       Impact factor: 2.135

View more
  5 in total

1.  Are on-the-day group and save samples required for elective shoulder, hip and knee arthroplasties?

Authors:  L Hainsworth; J Tracy; C Spolton-Dean; O Donaldson
Journal:  Ann R Coll Surg Engl       Date:  2018-10-05       Impact factor: 1.891

2.  Eliminating the use of allogeneic blood products in adolescent idiopathic scoliosis surgery.

Authors:  Mark J Berney; Peter H Dawson; Margaret Phillips; Darren F Lui; Paul Connolly
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-03-27

3.  Preoperative haemoglobin cut-off values for the prediction of post-operative transfusion in total knee arthroplasty.

Authors:  Jared Ze Yang Yeh; Jerry Yongqiang Chen; Hamid Rahmatullah Bin Abd Razak; Bryan Huai Gu Loh; Ying Hao; Andy Khye Soon Yew; Shi-Lu Chia; Ngai Nung Lo; Seng Jin Yeo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-05-28       Impact factor: 4.342

4.  The results of a stepwise implementation of a fast-track program in total hip and knee replacement patients.

Authors:  Georgios I Drosos; Ioannis E Kougioumtzis; Stylianos Tottas; Athanasios Ververidis; Christos Chatzipapas; Grigorios Tripsianis; Konstantinos Tilkeridis
Journal:  J Orthop       Date:  2020-03-25

5.  A Patient-Focused Technology-Enabled Program Improves Outcomes in Primary Total Hip and Knee Replacement Surgery.

Authors:  Prakash Jayakumar; Jianing Di; Jiayu Fu; Joyce Craig; Vicki Joughin; Victoria Nadarajah; Jade Cope; Marcus Bankes; Peter Earnshaw; Zameer Shah
Journal:  JB JS Open Access       Date:  2017-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.